𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Loss of p16INK4a expression is associated with vascular endothelial growth factor expression in squamous cell carcinoma of the esophagus

✍ Scribed by Hiroya Takeuchi; Soji Ozawa; Chih-Horng Shih; Nobutoshi Ando; Yuko Kitagawa; Masakazu Ueda; Masaki Kitajima


Publisher
John Wiley and Sons
Year
2004
Tongue
French
Weight
311 KB
Volume
109
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Vascular endothelial growth factor (VEGF) expression has been suggested to correlate with intratumoral microvessel density, tumor advancement and prognosis in esophageal squamous cell carcinoma (ESCC). Previous studies have showed that disruption of cell cycle regulator p16 is related to oncogenesis and tumor progression in ESCC. We hypothesized that VEGF expression in ESCC is reflected by abnormalities in the p16^INK4a^ gene. To clarify the regulatory role of p16^INK4a^ in VEGF expression in vitro, we transferred the p16^INK4a^ gene into a p16^INK4a^‐deleted ESCC cell line and observed changes in VEGF expression. Furthermore, we immunohistochemically assessed the expression of the cell cycle regulators (p16, p53 and RB) and VEGF in 90 surgically resected specimens of ESCC. Introduction of p16^INK4a^ cDNA by the p16 expression vector significantly suppressed cell proliferation in the p16^INK4a^‐deleted cell line TE8 (p < 0.0001). VEGF secretion by TE8 cells transfected with the p16^INK4a^ vector was significantly suppressed as compared to non‐transfected TE8 cells (p < 0.0001) and TE8 cells transfected with a control vector (p = 0.0015). The immunohistochemical studies of ESCC primary tumor specimens showed that loss of p16 expression was significantly correlated with VEGF‐positive expression (p = 0.0004). The cumulative postoperative survival rate in the group with p16‐positive and VEGF‐negative expression was significantly higher than in the other groups. Neither p53 nor RB expression had any impact on outcome. Aberrant p53 expression tended to be associated with VEGF expression, but the trend did not reach statistical significance. Our study demonstrated that VEGF expression was correlated with p16 expression in ESCC. Our results suggest that p16 may have a regulatory role in VEGF expression in ESCC. Β© 2004 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Vascular endothelial growth factor C and
✍ Csilla Neuchrist; Bohan M. Erovic; Allesandra Handisurya; Michael B. Fischer; Ge πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 379 KB πŸ‘ 1 views

## Abstract ## Background and Methods. VEGF proteins and their receptors are involved in tumor vessel neoformation. The third VEGF receptor, VEGFR3 (flt‐4) is important during both blood vessel development and lymphatic vessel formation. Because HNSCC preferentially metastasizes to regional lymph

Expression of vascular endothelial growt
✍ Ching-Chiang Yang; Kang-Chu Chu; Wen-Meng Yeh πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 137 KB

## Abstract Vascular endothelial growth factor (VEGF) functions as a regulator of neovascularization in malignant cells. VEGF as a mitogen is thought to alter renal cell carcinoma formation and tumor progression. We investigated the expression of the VEGF gene in order to evaluate its clinical sign

Vascular endothelial growth factor expre
✍ Kimitoshi Inoue; Yuichi Ozeki; Toshiyuki Suganuma; Yoshiaki Sugiura; Susumu Tana πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 245 KB πŸ‘ 2 views

## Background: Angiogenesis is essential for solid tumor growth and metastasis. vascular endothelial growth factor (vegf), a recently identified growth factor with significant angiogenic properties, may be a major tumor angiogenesis regulator in vivo. conversely, there have been few studies of the